Brief: EQL Pharma Q1 Operating Profit Rises To SEK 11.6 Mln

EQL Pharma AB

27/08/2020 06:34

Aug 27 (Reuters) - EQL Pharma AB  EQL.TE :
    * INTERIM REPORT APRIL - JUNE
    * GROUP'S SALES DURING Q1 AMOUNTED TO SEK 99.5 (14.5)
MILLION
    * Q1 OPERATING PROFIT AMOUNTED TO SEK 11.6 (0.08) MILLION
    * TOO EARLY TO SAY HOW EXPANSION OF OUR PRODUCT LINE TO
INCLUDE
MEDICAL DEVICES AND HEALTHCARE CONSUMABLES WILL AFFECT OUR
GROWTH
    * WE WILL CONTINUE TO INVEST IN A EUROPEAN EXPANSION OF OUR
PRODUCT PORTFOLIO AND PIPELINE

Source text for Eikon:  ID:nWkr17kVnz 
Further company coverage:  EQL.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))